GARIBOTTO, GIACOMO
 Distribuzione geografica
Continente #
EU - Europa 34.089
AS - Asia 4.174
NA - Nord America 3.307
Continente sconosciuto - Info sul continente non disponibili 525
SA - Sud America 370
AF - Africa 77
OC - Oceania 7
Totale 42.549
Nazione #
IT - Italia 33.300
US - Stati Uniti d'America 3.080
SG - Singapore 1.704
CN - Cina 1.093
VN - Vietnam 654
BD - Bangladesh 306
FR - Francia 301
BR - Brasile 226
FI - Finlandia 147
HK - Hong Kong 145
DE - Germania 93
CA - Canada 91
AR - Argentina 64
MX - Messico 59
GB - Regno Unito 52
JP - Giappone 49
CH - Svizzera 41
NL - Olanda 33
IQ - Iraq 31
IN - India 30
ID - Indonesia 28
JM - Giamaica 23
IE - Irlanda 22
PK - Pakistan 20
EC - Ecuador 19
ZA - Sudafrica 19
CO - Colombia 18
ES - Italia 14
RU - Federazione Russa 14
PH - Filippine 13
PL - Polonia 13
DZ - Algeria 12
KR - Corea 12
PY - Paraguay 12
TH - Thailandia 12
CR - Costa Rica 11
UA - Ucraina 11
CL - Cile 8
EG - Egitto 8
KE - Kenya 8
MA - Marocco 8
TR - Turchia 8
AU - Australia 7
AZ - Azerbaigian 7
SA - Arabia Saudita 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
LB - Libano 6
NP - Nepal 6
PE - Perù 6
SV - El Salvador 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
LT - Lituania 5
PR - Porto Rico 5
TW - Taiwan 5
UY - Uruguay 5
BO - Bolivia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
HN - Honduras 4
JO - Giordania 4
OM - Oman 4
PA - Panama 4
TN - Tunisia 4
UZ - Uzbekistan 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BE - Belgio 3
ET - Etiopia 3
HR - Croazia 3
IR - Iran 3
MY - Malesia 3
NG - Nigeria 3
NI - Nicaragua 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
AT - Austria 2
AW - Aruba 2
BG - Bulgaria 2
BJ - Benin 2
CI - Costa d'Avorio 2
GE - Georgia 2
HU - Ungheria 2
KZ - Kazakistan 2
LV - Lettonia 2
MN - Mongolia 2
MT - Malta 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SE - Svezia 2
SY - Repubblica araba siriana 2
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
Totale 42.011
Città #
Genova 18.468
Genoa 8.868
Rapallo 3.339
Vado Ligure 2.222
Singapore 841
San Jose 680
Ashburn 286
Lauterbourg 270
Ho Chi Minh City 193
Beijing 185
New York 152
Helsinki 141
Hanoi 140
Hong Kong 138
Council Bluffs 122
Santa Clara 106
Bordighera 92
Frankfurt am Main 77
Los Angeles 75
Tokyo 42
Dallas 41
Zurich 38
Mexico City 36
Tianjin 33
Haiphong 31
Chicago 30
Rome 30
São Paulo 30
Orem 27
Milan 26
Phoenix 24
Brooklyn 22
Buffalo 22
Da Nang 22
Dublin 21
Atlanta 20
Biên Hòa 20
Boardman 20
Toronto 20
Montreal 17
Amsterdam 16
Jacksonville 16
Princeton 16
Kingston 15
Naples 15
St Louis 15
Baghdad 14
London 14
Philadelphia 14
Washington 14
Houston 12
Queens 12
Shanghai 12
Columbus 11
Charlotte 10
Hải Dương 10
Asunción 9
Bắc Ninh 9
Cardiff 9
Denver 9
Miami 9
San Antonio 9
San Francisco 9
City of London 8
Des Moines 8
Guangzhou 8
Johannesburg 8
Madrid 8
Ninh Bình 8
Rio de Janeiro 8
Warsaw 8
Bogotá 7
Bologna 7
Chennai 7
Cincinnati 7
Detroit 7
Las Vegas 7
Milwaukee 7
Nairobi 7
Quito 7
Richmond 7
San José 7
Seattle 7
The Bronx 7
Alexandria 6
Bari 6
Boston 6
Can Tho 6
Lappeenranta 6
Memphis 6
Minneapolis 6
Orlando 6
Phủ Lý 6
Pittsburgh 6
Quảng Ngãi 6
Rawalpindi 6
Rochester 6
San Juan 6
San Salvador 6
Verona 6
Totale 37.497
Nome #
1,25-Dihydroxy vitamin D and coronary microvascular function 386
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 344
L'AMMONIOGENESI RENALE NELL'UOMO 337
Homocysteine exchange across skeletal muscle in patients with chronic kidney disease 318
APOPTOSIS AND MYOSTATIN mRNA ARE UPREGULATED IN THE SKELETAL MUSCLE OF PATIENTS WITH CHRONIC KIDNEY DISEASE 239
Interorgan handling of fibroblast growth factor-23 in humans 216
Soluble Toll-like Receptor 4: A New Player in Subclinical Inflammation and Malnutrition in Hemodialysis Patients 215
Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response. 214
Androgen-mediated apoptosis of kidney tubule cells: role of c-Jun amino terminal kinase 212
Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis. 212
Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment 212
Evaluation of Metabolic Acidosis in Patients With a Kidney Graft: Comparison of the Bicarbonate-Based and Strong Ion–Based Methods 203
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 202
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 202
Circadian monitoring of gastric juice mutagenicity. 201
Arteriovenous fistula of the native kidney: diagnosis by duplex Doppler ultrasound. 198
Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients 196
Effects of uremia and inflammation on growth hormone resistance in patients with chronic kidney diseases 194
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 194
Amino acid and protein metabolism in the human kidney and in patients with chronic kidney disease 193
Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease 191
Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4 191
Failure to remove de novo donor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss – a retrospective study 190
REPORT SUI DATI RACCOLTI DURANTE LA GIORNATA MONDIALE DEL RENE IN ITALIA NEGLI ANNI 2015-2016- Report for the World Kidney Days in Italy 2015-2016 189
Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4. 188
Indoxyl Sulfate Induces Renal Fibroblast Activation through a Targetable Heat Shock Protein 90-Dependent Pathway 186
Postanaesthetic myoglobinuric renal failure: an isolated expression of malignant hyperthermia. 185
Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities 183
Emerging role of myostatin and its inhibition in the setting of chronic kidney disease 183
Early interstitial macrophage infiltration with mild dysfunction is associated with subsequent kidney graft loss 182
Interorgan exchange of aminothiols in humans 180
Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells 176
The Organ Handling of Soluble Klotho in Humans 176
Inter-organ leptin exchange in humans 175
Secondary Membranous Nephropathy Due to Benign Tumors in 2 Young Women: A Case Report 175
Effects of Low-Protein, and Supplemented Very Low–Protein Diets, on Muscle Protein Turnover in Patients With CKD 173
Abnormal amino acid metabolism after amino acid ingestion in chronic renal failure 172
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 172
The control of muscle protein turnover in patients on peritoneal dialys 170
Peripheral tissue release of interleukin-6 in patients with chronic kidney diseases: Effects of end-stage renal disease and microinflammatory state 169
Regression of asymptomatic cardiomyopathy and clinical outcome of renal transplant recipients: a long-term prospective cohort study. 169
Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria 169
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 167
Primary hyperoxaluria: a report of a case. 165
Amino acid loss with polyethersulfone. 165
Inter-organ amino acid exchange. 164
AMINO ACID METABOLISM AND THE LIVER IN RENAL FAILURE 163
INDIVIDUAZIONE DEL RUOLO DELLA GLUTAMINASI FOSFATO-DIPENDENTE E DELLA GLUTAMINASI FOSFATO-INDIPENDENTE NELLA PRODUZIONE RENALE DI AMMONIACA 162
Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition 162
Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. 162
Muscle amino acid metabolism and the control of muscle protein turnover in patients with chronic renal failure. 161
Amino acid imbalance in patients with chronic renal failure. 159
Low-protein diets for chronic kidney disease patients: the Italian experience 159
PROTEIN TURNOVER IN THE HUMAN KIDNEY 158
Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups 158
The nuclear phosphatase SCP4 regulates FoxO transcription factors during muscle wasting in chronic kidney disease 158
Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy 158
Gene expression in highly sensitized dialysis patients waiting for a kidney transplant: A real-time PCR analysis 157
STUDY OF BIOASSAYABLE SOMATOMEDIN ON RENAL ARTERY AND VEIN 156
Acute renal failure due to acute bilateral renal artery thrombosis: successful surgical revascularization after prolonged anuria. 156
Awareness of kidney diseases in general population and in high school students. Italian report for World Kidney Days 2010-2011 156
Mechanisms of renal ammonia production and protein turnover 156
Immunohistochemical Staining of TLR4 in Human Skeletal Muscle Samples 155
Role of haematological, pulmonary and renal complications in the long-term prognosis of patients with lysinuric protein intolerance. 154
Risk factors for kidney diseases and awareness of blood pressure and proteinuria in general population and in high school students: Italian report for World Kidney Days 2012-2013 154
Myostatin: A Playmaker in Chronic Kidney Disease and Vascular Damage 153
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. I. Studies in the postabsorptive state 152
Central role of PKCdelta in glycoxidation-dependent apoptosis of human neurons 152
Kidney protein dynamics and ammoniagenesis in humans with chronic metabolic acidosis 151
EFFECTS OF CHRONIC RENAL INSUFFICIENCY AND METABOLIC ACIDOSIS ON GLUTAMINE METABOLISM IN MAN 151
Leptin as a uremic toxin interferes with neutrophil chemotaxis 151
Role of PKC-delta activity in glutathione-depleted neuroblastoma cells 149
Apoptosis in the kidneys of patients with type 2 diabetic nephropathy. 149
Eating During Hemodialysis Treatment: A Consensus Statement From the International Society of Renal Nutrition and Metabolism 149
Hypernatremia associated with severe rhabdomyolysis. 149
Renal and extra-renal handling of glutathione in humans 148
Phenylalanine hydroxylation across the kidney in humans 148
Renal ammoniagenesis in man with chronic potassium depletion. 148
Renal ammoniagenesis in an early stage of metabolic acidosis in man 148
Kidney and splanchnic handling of Interleukin-6 in humans 148
Low protein diets and plant-based low protein diets: Do they meet protein requirements of patients with chronic kidney disease? 148
De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients 147
Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk 147
Reversed-phase high-performance liquid chromatographic analysis of branched-chain keto acid hydrazone derivatives: optimization of techniques and application to branched-chain keto acid balance studies across the forearm. 146
Effects of microinflammation on growth hormone's sensitivity of potassium and amino acid metabolism in patients with chronic renal failure. 146
SPLANCHNIC AMINO ACID AND PROTEIN TURNOVER IN HUMANS: INSIGHT FROM ISOTOPE DILUTION AND CATHETERIZATION STUDIES 145
Multiple venous sampling for catecholamine assay in the diagnosis of malignant pheochromocytoma 145
Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection. 145
ALTERATA TRASMISSIONE INTRACELLULARE DI UN SEGNALE DEI FATTORI DI CRESCITA E STATO MICROINFIAMMATORIO SONO ASSOCIATI A DIFFERENTI EFFETTI CATABOLICI NEL MUSCOLO SCHELETRICO DEI PAZIENTI CON INSUFFICIENZA RENALE CRONICA 144
PULSE VERSUS DAILY ORAL CYCLOPHOSPHAMIDE FOR INDUCTION OF REMISSION IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS: A RANDOMIZED TRIAL 144
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up 144
DETERMINANTS OF THE PARTITION OF RENAL AMMONIA PRODUCTION BETWEEN URINE AND VENOUS BLOOD IN MAN WITH METABOLIC ACID-BASE DISTURBANCES 144
New Treatment Options for Hyperkalemia in Patients with Chronic Kidney Disease 144
Muscle protein synthesis and degradation in hemodialysis (HD) patients with protein-energy malnutrition (PEM) 143
Effects of chronic metabolic acidosis on splanchnic protein turnover and oxygen consumption in human beings 143
[Activity of renal enzymes producing ammonia from glutamine in the absence of phosphate: 2. Effect of phosphate dependent glutaminase inhibition by heating]. 143
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. II. Studies after amino acid ingestion 143
Renal metabolism of amino acids in early insulin-dependent diabetes mellitus 143
Apoptosis induced by serum withdrawal in human mesangial cells. Role of IGFBP-3 142
LONG-TERM RESPONSE OF RENAL FUNCTION IN CRESCENTIC MEMBRANOUS GLOMERULONEPHRITIS AFTER PLASMA EXCHANGE AND IMMUNOSUPPRESSIVE THERAPY 142
Totale 17.431
Categoria #
all - tutte 138.886
article - articoli 113.975
book - libri 350
conference - conferenze 10.751
curatela - curatele 1.198
other - altro 1.322
patent - brevetti 0
selected - selezionate 0
volume - volumi 11.290
Totale 277.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.767 102 320 239 399 181 270 205 857 150 333 231 480
2022/20233.966 372 210 46 384 610 725 16 329 752 58 388 76
2023/20242.038 88 280 42 221 151 392 124 162 135 41 157 245
2024/20255.908 147 423 172 412 736 550 494 894 232 305 617 926
2025/202610.591 1.187 244 620 914 1.432 1.015 1.806 551 738 1.037 563 484
2026/20271.186 1.186 0 0 0 0 0 0 0 0 0 0 0
Totale 42.549